Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The enzyme encoded by PNPO catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Zusätzlich bieten wir Ihnen PNPO Proteine (15) und PNPO Kits (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 75 products:
Human Polyclonal PNPO Primary Antibody für ELISA, WB - ABIN565829
Khayat, Korman, Frankel, Weintraub, Hershckowitz, Sheffer, Ben Elisha, Wevers, Falik-Zaccai: PNPO deficiency: an under diagnosed inborn error of pyridoxine metabolism. in Molecular genetics and metabolism 2008
Show all 2 Pubmed References
Cow (Bovine) Polyclonal PNPO Primary Antibody für WB - ABIN2787718
Song, Ueno, Numata, Iga, Shibuya-Tayoshi, Nakataki, Tayoshi, Yamauchi, Sumitani, Tomotake, Tada, Tanahashi, Itakura, Ohmori: Association between PNPO and schizophrenia in the Japanese population. in Schizophrenia research 2007
Show all 2 Pubmed References
Exome sequencing revealed that the patient was compound heterozygous for pathogenic mutations [c.546+1G>A (IVS5+1 G>A) and c.620delG (p.G207VfsX215)] in the PNPO gene.
One sequence variant, R116Q, a single nucleotide polymorphism that has been reported in the general population, was found to have an effect on PNPO activity.
Challenge to the paradigm of exclusive PLP (zeige PLP1 Antikörper) responsiveness in patients with pyridoxal 5'-phosphate oxidase deficiency and underlines the importance of consecutive testing of pyridoxine and PLP (zeige PLP1 Antikörper) in neonates with antiepileptic drug-resistant seizures.
Generalized epilepsies implicates susceptibility genes: CHRM3 (zeige CHRM3 Antikörper) at 1q43, VRK2 (zeige VRK2 Antikörper) at 2p16.1, ZEB2 (zeige ZEB2 Antikörper) at 2q22.3, SCN1A (zeige SCN1A Antikörper) at 2q24.3 and PNPO at 17q21.32.
provide evidence that a single arginine residue of the C terminus of pyridoxal 5'-phosphate synthase is responsible for coordinating co-operativity in this elaborate protein machinery
Results describe a combined computer and biochemical approach to characterize human pyridoxine 5'-phosphate oxidase (PNPO).
We examined 8 single nucleotide polymorphisms (SNPs) in PNPO and its 5'-flanking regions in 359 schizophrenia patients and 582 control subjects.
Sequencing of the PNPO gene revealed a novel homozygous nonsense mutationt in exon 3 in the neonatal and infantile seizure.
PNP (zeige NP Antikörper) oxidase R229W mutation identified in patients with neonatal epileptic encephalopathy sgnificantly affect the catalytic efficiency of the enzyme.
The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy.
, pyridoxamine 5'-phosphate oxidase
, Pyridoxamine 5'-phosphate oxidase
, pyridoxal 5'-phosphate synthase
, pyridoxamine-phosphate oxidase
, pyridoxine 5'-phosphate oxidase
, pyridoxine 5-phosphate oxidase